• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性黑色素瘤患者中与泛素化相关的生物标志物及其在肿瘤微环境中的作用。

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment.

作者信息

Zhang Li, Shi Zhehao, Zhang Fan, Chen Bin, Qiu Wei, Cai Lei, Lin Xiaohua

机构信息

Department of Dermatology and Venereology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

Front Oncol. 2023 May 19;13:1170190. doi: 10.3389/fonc.2023.1170190. eCollection 2023.

DOI:10.3389/fonc.2023.1170190
PMID:37274231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10235493/
Abstract

BACKGROUND

Skin cutaneous melanoma (SKCM) is the deadliest type of cutaneous malignancy. Ubiquitination is a process of protein sorting and degradation that exhibits multiple functions in the progression of various tumors. This study aimed to characterize a set of genes for ubiquitination in SKCM.

METHODS

The expression patterns of ubiquitin-associated genes (URGs) and the corresponding clinical information in SKCM tissues were comprehensively analyzed based on The Cancer Genome Atlas (TCGA) database. We performed univariate and multivariate Cox proportional regression models to characterize the risk scores and identify four critical genes related to prognostic ubiquitination (HCLS1, CORO1A, NCF1 and CCRL2), which were used to construct the prognostic signatures. We also studied the effects of HCLS1, CORO1A and CCRL2 on tumor metastasis-related indicators at the cellular level through experiments.

RESULTS

SKCM patients in the low-risk group showing a longer survival than those in the high-risk group. Characteristic risk scores correlated with several clinicopathological variables and reflected the infiltration of multiple immune cells. In addition, the knockdown of CLS1, CORO1A and CCRL2 affected cellular malignant biological behavior through the EMT signaling pathway.

CONCLUSION

This study provides a novel and prospective strategy to improve the clinical survival of SKCM patients.

摘要

背景

皮肤黑色素瘤(SKCM)是最致命的皮肤恶性肿瘤类型。泛素化是一种蛋白质分选和降解过程,在各种肿瘤进展中发挥多种功能。本研究旨在鉴定一组SKCM中泛素化相关基因。

方法

基于癌症基因组图谱(TCGA)数据库全面分析SKCM组织中泛素相关基因(URGs)的表达模式及相应临床信息。我们进行单因素和多因素Cox比例回归模型以表征风险评分并鉴定四个与预后泛素化相关的关键基因(HCLS1、CORO1A、NCF1和CCRL2),这些基因用于构建预后特征。我们还通过实验在细胞水平研究了HCLS1、CORO1A和CCRL2对肿瘤转移相关指标的影响。

结果

低风险组的SKCM患者比高风险组患者生存期更长。特征性风险评分与多个临床病理变量相关,并反映多种免疫细胞的浸润情况。此外,敲低CLS1、CORO1A和CCRL2通过EMT信号通路影响细胞恶性生物学行为。

结论

本研究为改善SKCM患者临床生存期提供了一种新的前瞻性策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/8664246153ad/fonc-13-1170190-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/4c32a04420fd/fonc-13-1170190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/c78f60da2e16/fonc-13-1170190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/f4e24b1f7ee2/fonc-13-1170190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/4d19244ccf40/fonc-13-1170190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/631f542797cb/fonc-13-1170190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/9b99fa03a1b7/fonc-13-1170190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/9e8aad341f9b/fonc-13-1170190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/80711a3a856b/fonc-13-1170190-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/8664246153ad/fonc-13-1170190-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/4c32a04420fd/fonc-13-1170190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/c78f60da2e16/fonc-13-1170190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/f4e24b1f7ee2/fonc-13-1170190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/4d19244ccf40/fonc-13-1170190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/631f542797cb/fonc-13-1170190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/9b99fa03a1b7/fonc-13-1170190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/9e8aad341f9b/fonc-13-1170190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/80711a3a856b/fonc-13-1170190-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12a/10235493/8664246153ad/fonc-13-1170190-g009.jpg

相似文献

1
Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment.转移性黑色素瘤患者中与泛素化相关的生物标志物及其在肿瘤微环境中的作用。
Front Oncol. 2023 May 19;13:1170190. doi: 10.3389/fonc.2023.1170190. eCollection 2023.
2
The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.皮肤黑色素瘤肿瘤微环境全景揭示了一个与预后和免疫治疗相关的基因特征。
Front Cell Dev Biol. 2021 Oct 1;9:739594. doi: 10.3389/fcell.2021.739594. eCollection 2021.
3
Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.基于免疫基因集的皮肤黑色素瘤预后标志物的开发和验证。
Future Oncol. 2021 Nov;17(31):4115-4129. doi: 10.2217/fon-2021-0104. Epub 2021 Jul 22.
4
Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.建立一个与 IFNγ 反应相关的特征,用于预测皮肤黑色素瘤的生存情况。
Cancer Med. 2020 Nov;9(21):8186-8201. doi: 10.1002/cam4.3438. Epub 2020 Sep 9.
5
A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.一个与细胞坏死相关的基因特征可预测皮肤黑色素瘤的预后。
Dis Markers. 2022 Nov 16;2022:8232024. doi: 10.1155/2022/8232024. eCollection 2022.
6
Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma.补体C1Q(C1QA、C1QB和C1QC)在皮肤黑色素瘤中的预后及免疫相关价值
Front Genet. 2022 Aug 30;13:940306. doi: 10.3389/fgene.2022.940306. eCollection 2022.
7
Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.全面分析 IFIT 家族在皮肤黑色素瘤中的预后和生物学意义。
Int Immunopharmacol. 2021 Dec;101(Pt A):108344. doi: 10.1016/j.intimp.2021.108344. Epub 2021 Nov 8.
8
Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.基于免疫基因组分析的免疫亚型分析为皮肤黑色素瘤鉴定出预后特征。
Int Immunopharmacol. 2020 Dec;89(Pt A):107162. doi: 10.1016/j.intimp.2020.107162. Epub 2020 Nov 7.
9
Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.天冬氨酸β-羟化酶结构域包含 1 作为与皮肤黑色素瘤免疫浸润相关的预后标志物。
BMC Cancer. 2023 Mar 31;23(1):292. doi: 10.1186/s12885-023-10625-8.
10
TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.TREM2 作为皮肤黑色素瘤微环境中患者预后的潜在免疫相关生物标志物。
Dis Markers. 2023 Jan 27;2023:8101837. doi: 10.1155/2023/8101837. eCollection 2023.

引用本文的文献

1
A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer.一种基于新型泛素相关基因的特征在喉癌的预后预测、免疫格局塑造和治疗选择方面显示出价值。
Front Pharmacol. 2025 Mar 20;16:1513948. doi: 10.3389/fphar.2025.1513948. eCollection 2025.
2
A novel model based on ubiquitination-related gene to predict prognosis and immunotherapy response in hepatocellular carcinoma.一种基于泛素化相关基因的新型模型,用于预测肝细胞癌的预后和免疫治疗反应。
Heliyon. 2024 Apr 9;10(8):e29387. doi: 10.1016/j.heliyon.2024.e29387. eCollection 2024 Apr 30.
3

本文引用的文献

1
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy.E3 泛素连接酶调节肿瘤微环境中的 PD-1/PD-L1 蛋白水平,以改善免疫治疗。
Front Immunol. 2023 Jan 17;14:1123244. doi: 10.3389/fimmu.2023.1123244. eCollection 2023.
2
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy.通过 E3 泛素连接酶靶向 CSC 相关转录因子进行癌症治疗。
Semin Cancer Biol. 2022 Dec;87:84-97. doi: 10.1016/j.semcancer.2022.11.002. Epub 2022 Nov 9.
3
Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation.
Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.
综合分析显示 SMARCD1 是皮肤黑色素瘤的一个潜在的生物标志物和治疗靶点。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11619-11634. doi: 10.1007/s00432-023-05064-8. Epub 2023 Jul 4.
Fbxo45 通过靶向 GGNBP2 进行泛素化和降解促进食管鳞癌细胞的恶性发展。
Oncogene. 2022 Oct;41(43):4795-4807. doi: 10.1038/s41388-022-02468-7. Epub 2022 Sep 20.
4
Fbxo22 promotes cervical cancer progression via targeting p57 for ubiquitination and degradation.Fbxo22 通过靶向 p57 促进宫颈癌进展,导致其泛素化和降解。
Cell Death Dis. 2022 Sep 20;13(9):805. doi: 10.1038/s41419-022-05248-z.
5
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.揭示器官特异性黑色素瘤转移部位的肿瘤免疫微环境。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-004884.
6
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer.非小细胞肺癌患者血浆外泌体的蛋白质组学分析
Transl Lung Cancer Res. 2022 Jul;11(7):1434-1452. doi: 10.21037/tlcr-22-467.
7
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.通过 E3 泛素连接酶靶向基质金属蛋白酶以调节肿瘤微环境用于癌症治疗。
Semin Cancer Biol. 2022 Nov;86(Pt 2):259-268. doi: 10.1016/j.semcancer.2022.06.004. Epub 2022 Jun 18.
8
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation.Fbxo45 通过靶向 USP49 促进胰腺癌的进展。
Cell Death Dis. 2022 Mar 12;13(3):231. doi: 10.1038/s41419-022-04675-2.
9
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.非典型趋化因子受体 CCRL2 在骨髓增生异常综合征和继发性急性髓系白血病中的作用。
Sci Adv. 2022 Feb 18;8(7):eabl8952. doi: 10.1126/sciadv.abl8952.
10
Mechanisms of immune activation and regulation: lessons from melanoma.免疫激活和调节的机制:黑色素瘤的启示。
Nat Rev Cancer. 2022 Apr;22(4):195-207. doi: 10.1038/s41568-022-00442-9. Epub 2022 Feb 1.